Transforming therapy for Acral and Mucosal Melanom...
Mona Foth‘s Abstract Acral and mucosal melanomas(A&MM) are rare but aggressive types of melanoma, making up less than 5% of all cases. Unlike the more common typ...
Mona Foth‘s Abstract Acral and mucosal melanomas(A&MM) are rare but aggressive types of melanoma, making up less than 5% of all cases. Unlike the more common typ...
Emma Clark’s Abstract Melanoma is a disease that places an incredible physical, financial, and emotional burden upon our society. Treatment options for melanoma have ...
Chenxu Shi’s Abstract Melanoma is a deadly form of skin cancer, and while new immunotherapy treatments have significantly improved survival, not all patients respond ...
Dong Ren’s Abstract Sinonasal mucosal melanoma (SNMM) is a rare high-grade malignancy involving the sinonasal tract, primarily including the nasal cavity, turbinates,...
Devarati Mitra’s Abstract Patients with mucosal melanoma are likely to have poor outcomes with current standard-of-care treatment options. The reasons are multifactor...
Medical Student Award – Pritika Parmar
Description: Mucosal melanoma (MM) is a rare form of melanoma with poor survival outcomes. Data on treatment for MM is limited to results from studies on cutaneous melanoma...
Medical Student Awards – Michael Chang
Immunotherapy has fundamentally changed the way we treat melanoma patients. Checkpoint blockade specifically, which unleashes T cell killing of cancer cells, has extended p...
Team Awards – Melanoma Research Program at Georgetown University
Mucosal melanoma presents a significant challenge for oncologists. Compared to cutaneous melanoma, mucosal melanoma has a far lower survival rate and is more difficult to t...
The Susan Fazio Melanoma Research Foundation Award Career Development Award – Iwei Yeh
Nov 22, 2025 PT